Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Clancy, JS"'
Autor:
Kline, KL, Msangi, S, Dale, VH, Woods, J, Souza, GM, Osseweijer, P, Clancy, JS, Hilbert, JA, Mugera, HK, McDonnell, PC, Johnson, FX
Addressing the challenges of understanding and managing complex interactions among food security, biofuels, and resource management requires a focus on specific contextual problems and opportunities. The United Nations’ 2030 Sustainable Development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::08a8594b34a2af27fa5c9ccf8fe5f16e
http://hdl.handle.net/10044/1/30128
http://hdl.handle.net/10044/1/30128
Publikováno v:
American Journal of Veterinary Research. 61:820-825
Objective—To evaluate fecal concentrations of selected genera of colonic bacteria in healthy dogs, and to investigate effects of dietary fructooligosaccharides (FOS) on those bacterial populations. Animals—6 healthy adult Beagles. Procedure—Dog
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chen J; Pfizer, New York, NY, USA.; Genentech, South San Francisco, CA, USA., Bearz A; National Cancer Institute, Aviano, Italy., Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea., Mamdani H; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Bauman J; Fox Chase Cancer Center, Philadelphia, PA, USA., Chiari R; Medical Oncology, AULSS6 Veneto, Padua, Italy., Ou SI; Chao Family Comprehensive Cancer Center, University of California at Irvine School of Medicine, Orange, CA, USA., Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Soo RA; National University Hospital Singapore, Singapore, Singapore., Felip E; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Shaw AT; Massachusetts General Hospital, Boston, MA, USA., Thurm H; Pfizer, La Jolla, CA, USA., Clancy JS; Pfizer, Cambridge, MA, USA., Lee K; Pfizer, Groton, CT, USA., O'Gorman M; Pfizer, Groton, CT, USA., Tanski C; Pfizer, Groton, CT, USA., Pithavala YK; Pfizer, La Jolla, CA, USA. yazdi.pithavala@pfizer.com.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Feb; Vol. 63 (2), pp. 171-182. Date of Electronic Publication: 2023 Dec 11.
Autor:
Peters S; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland. Electronic address: Solange.Peters@chuv.ch., Shaw AT; Massachusetts General Hospital, Boston, MA, USA. Electronic address: ashaw1@mgh.harvard.edu., Besse B; Gustave Roussy Cancer Campus, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: efelip@vhio.net., Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Electronic address: Ben.Solomon@petermac.org., Soo RA; National University Cancer Institute, Singapore. Electronic address: ross_soo@nuhs.edu.sg., Bearz A; National Cancer Institute, Aviano, Italy. Electronic address: abearz@cro.it., Gadgeel SM; University of Michigan/Rogel Cancer Center, Ann Arbor, MI, USA. Electronic address: sgadgeel@med.umich.edu., Lin CC; National Taiwan University Hospital, Taipei, Taiwan. Electronic address: cclin1@ntu.edu.tw., Kao S; Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia. Electronic address: Steven.Kao@lh.org.au., Seto T; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan. Electronic address: setocruise@gmail.com., Masters ET; Pfizer Oncology, New York, NY, USA. Electronic address: elizabeth.masters@pfizer.com., Abbattista A; Pfizer Oncology, Milan, Italy. Electronic address: antonello.abbattista@pfizer.com., Clancy JS; Pfizer Oncology, Cambridge, MA, USA. Electronic address: Jill.S.Clancy@pfizer.com., Thurm H; Pfizer Oncology, La Jolla, CA, USA. Electronic address: holger.thurm@pfizer.com., Reisman A; Pfizer Global Product Development, New York, NY, USA. Electronic address: Arlene.Reisman@pfizer.com., Peltz G; Pfizer Oncology, Groton, CT, USA. Electronic address: Gerson.Peltz@pfizer.com., Ross Camidge D; University of Colorado, Aurora, CO, USA. Electronic address: Ross.Camidge@ucdenver.edu.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Jun; Vol. 144, pp. 10-19. Date of Electronic Publication: 2020 Mar 10.
Autor:
Shaw AT; Massachusetts General Hospital, Boston, MA, USA. Electronic address: ashaw1@mgh.harvard.edu., Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Chiari R; Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy., Riely GJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Besse B; Gustave Roussy Cancer Campus, Villejuif, France; Department of Cancer Medicine, Paris-Sud University, Orsay, France., Soo RA; National University Cancer Institute, Singapore, Singapore., Kao S; Chris O'Brien Lifehouse, Camperdown, NSW, Australia., Lin CC; National Taiwan University Hospital, Taipei, Taiwan., Bauer TM; Sarah Cannon Cancer Research Institute and Tennessee Oncology, PLLC, Nashville, TN, USA., Clancy JS; Pfizer Global Product Development-Oncology, Cambridge, MA, USA., Thurm H; Pfizer Global Product Development-Oncology, La Jolla, CA, USA., Martini JF; Pfizer Global Product Development-Oncology, La Jolla, CA, USA., Peltz G; Pfizer Oncology, Groton, CT, USA., Abbattista A; Pfizer Global Product Development-Oncology, Milan, Italy., Li S; Pfizer Global Product Development-Oncology, La Jolla, CA, USA., Ou SI; University of California Irvine, Irvine, CA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Dec; Vol. 20 (12), pp. 1691-1701. Date of Electronic Publication: 2019 Oct 25.